Detalles de la búsqueda
1.
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Br J Cancer
; 128(1): 137-147, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36323878
2.
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.
J Pathol
; 256(4): 388-401, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34897700
3.
Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.
Breast Cancer Res Treat
; 191(3): 501-511, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34853987
4.
Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.
Gynecol Oncol
; 150(2): 239-246, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29807697
5.
Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.
Gynecol Oncol
; 142(3): 458-64, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27444035
6.
Concurrent RB1 Loss and BRCA-Deficiency Predicts Enhanced Immunological Response and Long-Term Survival in Tubo-Ovarian High-Grade Serous Carcinoma.
Clin Cancer Res
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38837893
7.
Our Faustian pact with the digital world.
Lancet Oncol
; 18(2): 171-172, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28214405
8.
Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma.
Transl Oncol
; 31: 101638, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36805919
9.
p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study.
J Pathol Clin Res
; 9(3): 208-222, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36948887
10.
Concurrent RB1 loss and BRCA-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma.
medRxiv
; 2023 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37986741
11.
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.
Clin Cancer Res
; 28(24): 5383-5395, 2022 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36222710
12.
Two-dimensional myocardial strain imaging detects changes in left ventricular systolic function immediately after anthracycline chemotherapy.
Eur J Echocardiogr
; 12(12): 945-52, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21965152
13.
New therapeutic opportunities for women with low-grade serous ovarian cancer.
Endocr Relat Cancer
; 29(1): R1-R16, 2021 11 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34636747
14.
Maximum Tolerated Dose and Anti-Tumor Activity of Intraperitoneal Cantrixil (TRX-E-002-1) in Patients with Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer: Phase I Study Results.
Cancers (Basel)
; 13(13)2021 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34206826
15.
ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
Clin Cancer Res
; 14(17): 5594-601, 2008 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18765553
16.
Ankyrin repeat domain 1, ANKRD1, a novel determinant of cisplatin sensitivity expressed in ovarian cancer.
Clin Cancer Res
; 14(21): 6924-32, 2008 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18980987
17.
Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.
J Circ Biomark
; 7: 1849454418782617, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30013673
18.
BRAF Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition.
JCO Precis Oncol
; 2: 1-14, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35135122
19.
MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.
Mayo Clin Proc
; 93(3): 307-320, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29502561
20.
Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study.
J Pathol Clin Res
; 4(4): 250-261, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30062862